forecast
Platform Technology Faces Competitive Substitution Risk
Moderna's main risks include drugs failing for unknown biological reasons and next-generation competitors, since alternative technologies may replace missing-protein therapy at scale and other mRNA companies could leapfrog Moderna.
forecastpending
Speaker
Matthew HarrisonEvidence Quote
“There are three or four or five other technologies that can potentially do that and potentially do it at scale.”
Created: 11/15/2026, 7:57:10 PM
Your notes
Loading notes...